SECsense Logo

Cellebrite DI Ltd. Leadership Shakeup: Interim CEO and New Board Appointments for 2025

$CLBT
Form 6-K
Filed on: 2025-01-06
Source
Cellebrite DI Ltd. Leadership Shakeup: Interim CEO and New Board Appointments for 2025

Here are the key insights extracted from the financial report (Form 6-K) of Cellebrite DI Ltd. for January 2025:

  1. Leadership Transition:
  • Thomas E. Hogan has been appointed as the interim CEO effective January 1, 2025. He was the chairman of the board prior to this appointment.
  • To ensure the separation of duties between the CEO and the Board chairman, Hogan will not serve as Board chairman during his interim tenure.
  • Adam H. Clammer, the current lead independent director, has assumed the role of Board chairman as of January 1, 2025.
  1. Board Appointment:
  • Michael D. Capellas has been appointed to the Board as a Class II director, effective January 1, 2025. He will serve until the annual meeting of shareholders in 2026.
  • Capellas replaces Clammer as the Board's lead independent director.
  1. Background of Michael D. Capellas:
  • Capellas has extensive leadership experience, having held positions such as:
    • Founder and CEO of Capellas Strategic Partners.
    • Founding Chairman and CEO of VCE (Virtual Computing Company).
    • Chairman and CEO of First Data Corporation.
    • CEO and director of MCI (previously WorldCom).
    • Chairman, President and CEO of Compaq Computer Corporation.
    • President of Hewlett-Packard Company post-merger with Compaq.
  • He is currently the lead independent director of Cisco Systems, Inc. and has served on various boards.
  1. Press Release:
  • On January 6, 2025, Cellebrite issued a press release announcing Michael D. Capellas' appointment as lead independent director.
  1. Compliance and Filing:
  • The report is submitted under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
  • It is incorporated by reference into the company's registration statements on Forms S-8 and F-3.
  1. Company Information:
  • Cellebrite DI Ltd.
  • Address: 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel.
  • Commission File Number: 001-40772.

This information highlights significant changes in the leadership structure of Cellebrite, which may impact the company's strategic direction and governance practices moving forward.